These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 6239983

  • 1. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L, Maini RN.
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract] [Full Text] [Related]

  • 2. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM, Biasi D, Caramaschi P, Codella O, Corrocher R, Serpelloni G, De Sandre G.
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract] [Full Text] [Related]

  • 3. Assessment of reticuloendothelial system function in man using receptor-specific probes.
    Hamburger MI.
    Neth J Med; 1984 Feb; 27(9):359-67. PubMed ID: 6239984
    [No Abstract] [Full Text] [Related]

  • 4. [Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases].
    Aleksandrova EN, Zimin IuI, Nasonov EL.
    Ter Arkh; 1984 Feb; 56(10):130-6. PubMed ID: 6084315
    [No Abstract] [Full Text] [Related]

  • 5. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P, Batko B, Skura A, Adamek-Guzik T, Cześnikiewicz-Guzik M, Krzanowski M, Rydz-Stryszowska I, Ryszawa N, Guzik TJ.
    Przegl Lek; 2006 Feb; 63(5):278-83. PubMed ID: 17036505
    [Abstract] [Full Text] [Related]

  • 6. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT, Koreshkov GG, Nasonov EL, Zakharchenko VN, Larionov SM.
    Ter Arkh; 1989 Feb; 61(5):51-5. PubMed ID: 2781490
    [No Abstract] [Full Text] [Related]

  • 7. [Antinuclear antibodies, anti-SSA(Ro) and SSB(La) in diffuse connective tissue diseases].
    Assad RL, Gabriel Júnior A, Iglesias SS, Cossermelli W.
    Rev Hosp Clin Fac Med Sao Paulo; 1986 Feb; 41(3):103-8. PubMed ID: 3551017
    [No Abstract] [Full Text] [Related]

  • 8. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G, Hiepe F.
    Z Arztl Fortbild (Jena); 1992 Mar 10; 86(5):217-22. PubMed ID: 1585674
    [No Abstract] [Full Text] [Related]

  • 9. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan 10; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 10. [Problems in the demonstration immune complexes].
    Sedlacek HH, Pernice W, Seiler FR.
    Internist (Berl); 1980 Apr 10; 21(4):220-6. PubMed ID: 6448232
    [No Abstract] [Full Text] [Related]

  • 11. [Natural biological models of autoimmune diseases].
    Pleskovskaia GN.
    Revmatologiia (Mosk); 1991 Apr 10; (4):38-44. PubMed ID: 1805332
    [No Abstract] [Full Text] [Related]

  • 12. The immunology of rheumatoid diseases.
    Koffler D.
    Clin Symp; 1979 Apr 10; 31(4):1-36. PubMed ID: 45382
    [No Abstract] [Full Text] [Related]

  • 13. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T, Eloranta ML, Kastner B, Wahren-Herlenius M, Alm GV, Rönnblom L.
    Arthritis Rheum; 2006 Jun 10; 54(6):1917-27. PubMed ID: 16729300
    [Abstract] [Full Text] [Related]

  • 14. Cryoglobulinemias and connective tissue diseases.
    Del Giacco GS, Locci F, Murru M, Cherchi MC.
    Ric Clin Lab; 1986 Jun 10; 16(2):295-300. PubMed ID: 3491412
    [Abstract] [Full Text] [Related]

  • 15. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Moriuchi J, Morita K, Hoshina Y, Horiki T.
    Tokai J Exp Clin Med; 1993 Dec 10; 18(3-6):133-8. PubMed ID: 7701526
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of complement-mediated solubilisation of antigen-antibody complexes by serum factor(s) in patients with various connective tissue diseases.
    Webb J, Zoma A, Cobb S, Veitch J, Whaley K.
    Aust N Z J Med; 1986 Aug 10; 16(4):445-51. PubMed ID: 3492194
    [Abstract] [Full Text] [Related]

  • 17. [Clinico-immunological characteristics of systemic lupus erythematosus with Raynaud and Sjögren's syndromes (report I)].
    Nasonova VA, Poverennyĭ AM, Nasonov EL, Lekakh IV, Tachmuradova MD.
    Ter Arkh; 1985 Aug 10; 57(5):94-8. PubMed ID: 3161200
    [Abstract] [Full Text] [Related]

  • 18. Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus.
    Winfield JB, Koffler D, Kunkel HG.
    J Clin Invest; 1975 Sep 10; 56(3):563-70. PubMed ID: 1080489
    [Abstract] [Full Text] [Related]

  • 19. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
    Nasonov EL, Aleksandrova EN, Sura VV, Ivanova MM, Zimin IuI.
    Ter Arkh; 1983 Sep 10; 55(7):32-7. PubMed ID: 6604958
    [No Abstract] [Full Text] [Related]

  • 20. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN, Joller-Jemelka HI, Grob PJ.
    Schweiz Med Wochenschr; 1974 Nov 09; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.